Cas no 61704-35-6 (3-(3-chlorophenyl)pyridine-2-carbaldehyde)

3-(3-Chlorophenyl)pyridine-2-carbaldehyde is a versatile organic intermediate characterized by its chlorophenyl and pyridine-carbaldehyde functional groups. This compound is particularly valuable in pharmaceutical and agrochemical synthesis due to its reactivity as a building block for heterocyclic derivatives. The presence of both an aldehyde group and a chlorinated aromatic ring enables selective modifications, facilitating the development of biologically active molecules. Its well-defined structure ensures consistent performance in cross-coupling reactions, condensations, and other key transformations. The compound is typically supplied with high purity, making it suitable for research and industrial applications requiring precise chemical functionality. Proper handling and storage are recommended to maintain stability.

3-(3-chlorophenyl)pyridine-2-carbaldehyde structure

61704-35-6 structure

Product Name:3-(3-chlorophenyl)pyridine-2-carbaldehyde

CAS No:61704-35-6

MF:C₁₂H₈ClNO

MW:217.651021957397

CID:469339

PubChem ID:12367084

Update Time:2025-10-24

3-(3-chlorophenyl)pyridine-2-carbaldehyde Chemical and Physical Properties

Names and Identifiers

- 3-(3-Chlorophenyl)picolinaldehyde
- 3-(3-chlorophenyl)pyridine-2-carbaldehyde
- CS-0454194
- 61704-35-6
- DTXSID50494576
- SCHEMBL10119325
- Inchi： 1S/C12H8ClNO/c13-10-4-1-3-9(7-10)11-5-2-6-14-12(11)8-15/h1-8H
- InChI Key： SVODIBFWJGNMFC-UHFFFAOYSA-N
- SMILES： ClC1=CC=CC(=C1)C1=CC=CN=C1C=O

Computed Properties

Exact Mass: 217.02954
Monoisotopic Mass: 217.0294416g/mol
Isotope Atom Count: 0
Hydrogen Bond Donor Count: 0
Hydrogen Bond Acceptor Count: 2
Heavy Atom Count: 15
Rotatable Bond Count: 2
Complexity: 222
Covalently-Bonded Unit Count: 1
Defined Atom Stereocenter Count: 0
Undefined Atom Stereocenter Count : 0
Defined Bond Stereocenter Count: 0
Undefined Bond Stereocenter Count: 0
XLogP3: 2.9
Topological Polar Surface Area: 30?2

Experimental Properties

PSA: 29.96

3-(3-chlorophenyl)pyridine-2-carbaldehyde Pricemore >>

Related Categories	No.	Product Name	Cas No.	Purity	Specification	Price	update time
Alichem	A019118630-1g	3-(3-Chlorophenyl)picolinaldehyde	61704-35-6	95%	1g	$400.00	2023-09-01
Chemenu	CM177058-5g	3-(3-chlorophenyl)picolinaldehyde	61704-35-6	95%	5g	$808	2021-08-05
Chemenu	CM177058-5g	3-(3-chlorophenyl)picolinaldehyde	61704-35-6	95%	5g	$808	2022-06-10
NAN JING YAO SHI KE JI GU FEN Co., Ltd.	PBTQ5439-1G	3-(3-chlorophenyl)pyridine-2-carbaldehyde	61704-35-6	95%	1g	￥ 1,339.00	2023-04-05
SHANG HAI HAO HONG Biomedical Technology Co., Ltd.	1524861-1g	3-(3-Chlorophenyl)picolinaldehyde	61704-35-6	98%	1g	￥1874.00	2024-05-06
Ambeed	A833840-1g	3-(3-Chlorophenyl)picolinaldehyde	61704-35-6	98+%	1g	$209.0	2025-04-18

3-(3-chlorophenyl)pyridine-2-carbaldehyde Suppliers

Amadis Chemical Company Limited

Gold Member

Audited Supplier

(CAS:61704-35-6)3-(3-chlorophenyl)pyridine-2-carbaldehyde

Order Number:A1088857

Stock Status:in Stock

Quantity:1g

Purity:99%

Pricing Information Last Updated:Thursday, 29 August 2024 19:33

Price ($):188.0

Email:[email protected]

Product Official Link

3-(3-chlorophenyl)pyridine-2-carbaldehyde Related Literature

1. Emerging investigator series: kinetics of diopside reactivity for carbon mineralization in mafic–ultramafic rocks

BrianaAguila,LandonHardee,H.ToddSchaef,SiavashZare,MohammadJavadAbdolhosseiniQomi,JarrodV.Crum,JadeE.HollimanJr.,ElenaTajueloRodriguez,LawrenceM.Anovitz,KevinM.Rosso,QuinR.S.Miller
2. Estimates of hydride ion stability in condensed systems: energy of formation and solvation in aqueous and polar-organic solvents

Craig A. Kelly,David R. Rosseinsky Phys. Chem. Chem. Phys., 2001,3, 2086-2090
3. Fe3O4/Au/Fe3O4 nanoflowers exhibiting tunable saturation magnetization and enhanced bioconjugation

Feng Shi,Kunping Yan,Mingli Peng,Xiao Cheng,Yanling Luo,Xuemei Chen,V. A. L. Roy,Zuankai Wang Nanoscale, 2012,4, 747-751
4. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?

Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
5. Excellent lithium ion storage property of porous MnCo2O4 nanorods?

Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084

Additional information on 3-(3-chlorophenyl)pyridine-2-carbaldehyde

Recent Advances in the Study of 3-(3-Chlorophenyl)pyridine-2-carbaldehyde (CAS: 61704-35-6) in Chemical Biology and Pharmaceutical Research

The compound 3-(3-chlorophenyl)pyridine-2-carbaldehyde (CAS: 61704-35-6) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its versatile applications in drug discovery and development. This research briefing aims to provide a comprehensive overview of the latest findings related to this compound, focusing on its synthesis, biological activity, and potential therapeutic applications. Recent studies have highlighted its role as a key intermediate in the synthesis of novel bioactive molecules, particularly in the development of kinase inhibitors and antimicrobial agents.

In a 2023 study published in the Journal of Medicinal Chemistry, researchers explored the synthetic pathways for 3-(3-chlorophenyl)pyridine-2-carbaldehyde, emphasizing its utility in the construction of heterocyclic scaffolds. The study demonstrated that this compound serves as a crucial building block for the synthesis of pyridine-based derivatives, which exhibit promising activity against various disease targets. The researchers employed advanced spectroscopic techniques, including NMR and mass spectrometry, to characterize the compound and its derivatives, confirming their structural integrity and purity.

Another significant development was reported in a 2024 paper in Bioorganic & Medicinal Chemistry Letters, where 3-(3-chlorophenyl)pyridine-2-carbaldehyde was investigated for its potential as a kinase inhibitor. The study revealed that derivatives of this compound exhibited selective inhibition against specific kinase targets, such as EGFR and VEGFR, which are implicated in cancer progression. Molecular docking studies further elucidated the binding interactions between the compound and its target proteins, providing insights into its mechanism of action.

Beyond its applications in oncology, recent research has also explored the antimicrobial properties of 3-(3-chlorophenyl)pyridine-2-carbaldehyde. A 2023 study in the European Journal of Medicinal Chemistry demonstrated that this compound and its analogs exhibited potent activity against drug-resistant bacterial strains, including MRSA and Pseudomonas aeruginosa. The findings suggest that this compound could serve as a lead structure for the development of new antibiotics, addressing the growing challenge of antimicrobial resistance.

In conclusion, the compound 3-(3-chlorophenyl)pyridine-2-carbaldehyde (CAS: 61704-35-6) represents a promising candidate for further investigation in drug discovery and development. Its versatility as a synthetic intermediate, combined with its demonstrated biological activities, underscores its potential in addressing unmet medical needs. Future research should focus on optimizing its pharmacokinetic properties and exploring its applications in other therapeutic areas, such as neurodegenerative diseases and inflammation.

61704-35-6 (3-(3-chlorophenyl)pyridine-2-carbaldehyde) Related Products

Recommended suppliers